Welcome to the e-CCO Library!

P0516: Chronic Rhinosinusitis and Inflammatory Bowel Disease: discovering the gut-lung axis- preliminary results from a single-center pilot study
Year: 2025
Source: ECCO'25
Authors: Marescax7x7x7 R.(1)*;Del Gaudiox7x7x7 A.(1);Iaccarinox7x7x7 J.(1);Murgianox7x7x7 M.(1);Sessax7x7x7 G.(1);Frascax7x7x7 P.(1);Migninix7x7x7 I.(1);Baglivox7x7x7 I.(1);Pugliesex7x7x7 D.(1);Rigantex7x7x7 M.(2);Zavarellax7x7x7 M.A.(1);Colantuonox7x7x7 S.(3);Laterzax7x7x7 L.(1);Papax7x7x7 A.(1);Gasbarrinix7x7x7 A.(1);Carusox7x7x7 C.(4);Scaldaferrix7x7x7 F.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0517: Role of radiomics in predicting the degree of intestinal fibrosis in patients with Crohn's Disease
Year: 2025
Source: ECCO'25
Authors: Laterzax7x7x7 L.(1);Marescax7x7x7 R.(1)*;Varcax7x7x7 S.(1);Tranx7x7x7 H.E.(2);Bocciax7x7x7 E.(2);Larosax7x7x7 L.(2);Sessax7x7x7 G.M.(1);Migninix7x7x7 I.(1);Sacchettix7x7x7 F.(3);Giustinianix7x7x7 M.C.(4);Boldrinix7x7x7 L.(2);Sofox7x7x7 L.(3);Minordix7x7x7 L.M.(2);Cammarotax7x7x7 G.(5);Papax7x7x7 A.(1);Gasbarrinix7x7x7 A.(1);Scaldaferrix7x7x7 F.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0518: Study of the prevalence of defecatory disorders in patients with quiescent ulcerative colitis using high resolution anorectal manometry
Year: 2025
Source: ECCO'25
Authors: Abdelatyx7x7x7 K.(1)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0519: Upadacitinib in Acute Severe Ulcerative Colitis among previously anti-TNFa exposed patients.
Year: 2025
Source: ECCO'25
Authors: Mantix7x7x7 M.(1)*;Kamperidisx7x7x7 N.(1);Toskasx7x7x7 A.(1);Misrax7x7x7 R.(1);Arebix7x7x7 N.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P051: Chemokines CXCL17, CCL20, and the receptor CXCR5 are overexpressed in the colonic mucosa from patients with active ulcerative colitis: CXCL17 is a potential marker of histological remission
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. Yamamoto-Furusho*1, E. Iturriaga-Goyon2, G. Fonseca-Camarillo1

Created: Friday, 22 February 2019, 9:49 AM
P051: DNA methylation signatures associated with pathogenesis Crohn's disease-related genes
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Moret Tatay1,2, E. Cerrillo1,3, E. Sáez-González1,3, D. Hervás4, M. Iborra1,2,3, J. Sandoval5, E. Busó6, L. Tortosa1,2, P. Nos1,2,3, B. Beltrán1,2,3

Created: Friday, 22 February 2019, 9:41 AM
P051: IFNγ-macrophages could mediate EMT in Crohn’s disease through the WNT pathway
Year: 2022
Source: ECCO'22
Authors: Edo, M.M.(1);Macias-Ceja, D.C.(2);Bauset, C.(2);Lis-Lopez, L.(2);Coll, S.(2);Seco-Cervera, M.(3);Cosin-Roger, J.(3);Calatayud, S.(2);Barrachina, M.D.(2);Ortiz-Masiá, D.(1);
Created: Friday, 11 February 2022, 3:52 PM
P051: Immune phenotypes in acute severe ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Meringer, H.(1)*;Canales-Herrerias, P.(2);Jha, D.(2);Livanos, A.(2);Jougon, J.(2);Cossarini, F.(3);Tankelevich, M.(2);Kayal, M.(2);Colombel, J.F.(2);Mehandru, S.(2);
Created: Friday, 14 July 2023, 10:48 AM
P051: Lower incidence of herpes zoster in vedolizumab-treated vs. tofacitinib-treated patients with ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

F. Caldera1*, K. Lasch2, T. Lissoos2, C. Cao2, F. Bhayat3

Created: Thursday, 21 February 2019, 9:14 AM
P051: Macrophages as a source of Notch Ligands in Crohn's disease: implications in fibrosis
Year: 2021
Source: ECCO'21 Virtual
Authors: Jorge, M.A.(1);Barrachina, M.D.(1);Bauset, C.(1);Gisbert-Ferrándiz, L.(1);Cosin-Roger, J.(2);Coll, S.(1);Calatayud, S.(1);López-Serrano, A.(3);Ortiz-Masiá, D.(4);
Created: Wednesday, 2 June 2021, 4:12 PM
P051: Use of digital technology to boost patient recruitment in inflammatory bowel disease clinical trials
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bouhnik Y.*1, Amiot A.2, Alexandre N.1, Attar A.1, Kondamudi P.K.3, Stéfanescu C.1

Created: Wednesday, 20 February 2019, 10:36 AM
P052 Nuclear magnetic resonance metabolomic profiling of IBD patients under anti-TNF treatment. Are the pathways network deregulated?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Notararigo1, M. Martin-Pastor2, J.E. Dominguez Munoz3, M. Barreiro-de Acosta3

Created: Thursday, 30 January 2020, 10:12 AM
P0520: Association between interoception and Visceral Hypervigilance in patients with Inflammatory Bowel Disease
Year: 2025
Source: ECCO'25
Authors: Knödlerx7x7x7 L.L.(1)*;Röschx7x7x7 T.(1);Atanasovax7x7x7 K.(1);Ebertx7x7x7 M.(1);Thomannx7x7x7 A.(1);Reindlx7x7x7 W.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0521: Accuracy of a non-invasive approach in monitoring pediatric inflammatory bowel disease: interim-analysis of a prospective multicenter italian study
Year: 2025
Source: ECCO'25
Authors: D'Arcangelox7x7x7 G.(1)*;Gravinax7x7x7 A.(1);Coluccix7x7x7 A.(2);Rasox7x7x7 T.(1);Casertanox7x7x7 M.(2);Cennix7x7x7 S.(2);Strisciugliox7x7x7 C.(2);Maccionix7x7x7 F.(3);Olivax7x7x7 S.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0522: Transmural healing rate does not differ between Crohn's disease patients with structural damage versus inflammatory behavior
Year: 2025
Source: ECCO'25
Authors: Marques Garciax7x7x7 P.(1)*;Albert Palomares x7x7x7 S.(1);Fquihi Chetouanix7x7x7 M.(1);Torrente Sánchezx7x7x7 J.(1); Pérez Ibáñezx7x7x7 A.A.(1);Rabadán Matax7x7x7 A.(1);Peiró Garcíax7x7x7 E.(1);Blanc Garciax7x7x7 E.(2);Martinez Perezx7x7x7 M.J.(2);Paredes Arquiolax7x7x7 J.M.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0523: Comparative analysis of two ELISA methods for measuring serum ustekinumab levels in Inflammatory Bowel Disease ¿Is interchangeability feasible?
Year: 2025
Source: ECCO'25
Authors: Dueñas-Prietox7x7x7 L.(1);Cabrera-Marantex7x7x7 Ó.(1);Algarax7x7x7 M.(2);Alfocea-Molinax7x7x7 Á.(1);Rafael de la Cruzx7x7x7 D.(2);Garcinuñox7x7x7 S.(3);Masedox7x7x7 Á.(2);Yelax7x7x7 C.(2);Lópezx7x7x7 F.(2);Olmedox7x7x7 C.(2);Casisx7x7x7 B.(2);Gonzalez LamaMD- PhDx7x7x7 Y.(2)*;
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0524: Advanced therapy optionsx7x7x7 choicex7x7x7 accessx7x7x7 and treatment empowerment for Inflammatory Bowel Disease (ADVOCATE-IBD): A UK-wide qualitative study
Year: 2025
Source: ECCO'25
Authors: Hardasanix7x7x7 R.(1)*;Radfordx7x7x7 S.(2);Peerallyx7x7x7 M.(3);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0525: Genome-wild gene expression analysis and identification of Crohn's disease from intestinal tuberculosis and primary intestinal lymphoma
Year: 2025
Source: ECCO'25
Authors: Linx7x7x7 L.(1);Wangx7x7x7 Y.(1)*;Zhaox7x7x7 X.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0526: Association of plasma IgA with bowel wall thickness and disease activity in IBD patients assessed by intestinal ultrasound
Year: 2025
Source: ECCO'25
Authors: Chenx7x7x7 Y.L.(1)*;Tsaix7x7x7 T.(1x7x7x72x7x7x73);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session
P0527: Bowel Ultrasound Scan (BUS) in Pediatric Acute Severe Colitis (ASC): a multicenter prospective study on behalf of the IBD Porto group
Year: 2025
Source: ECCO'25
Authors: Scarallox7x7x7 L.(1)*;Alvisix7x7x7 P.(2);Aloix7x7x7 M.(3);Bramuzzox7x7x7 M.(4);Broekaertx7x7x7 I.(5);De Laffoliex7x7x7 J.(6);Kierkusx7x7x7 J.(7);Matarx7x7x7 M.(8);Pranzettix7x7x7 A.(9);Renzox7x7x7 S.(1);Velasco Rodríguez-Belvísx7x7x7 M.(10);Strisciugliox7x7x7 C.(11);Tasciottix7x7x7 L.(12);Lionettix7x7x7 P.(1);
Created: Monday, 10 February 2025, 2:00 PM
Guided Poster Session